| Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response G Chen, AC Huang, W Zhang, G Zhang, M Wu, W Xu, Z Yu, J Yang, ... Nature 560 (7718), 382-386, 2018 | 2486 | 2018 |
| Stiff matrix induces exosome secretion to promote tumour growth B Wu, DA Liu, L Guan, PK Myint, LK Chin, H Dang, Y Xu, J Ren, T Li, Z Yu, ... Nature cell biology 25 (3), 415-424, 2023 | 129 | 2023 |
| Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang, SY Wang, WL Ren, ... Oncotarget 8 (33), 55715, 2017 | 108 | 2017 |
| HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors L Guan, B Wu, T Li, LA Beer, G Sharma, M Li, CN Lee, S Liu, C Yang, ... Nature communications 13 (1), 4078, 2022 | 58 | 2022 |
| Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling P Mo, Q Zhou, L Guan, Y Wang, W Wang, M Miao, Z Tong, M Li, S Majaz, ... Oncogene 34 (30), 3935-3945, 2015 | 42 | 2015 |
| Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis SM Zhang, QG Zhu, XX Ding, S Lin, J Zhao, L Guan, T Li, B He, HQ Zhang Cancer Management and Research, 3393-3404, 2018 | 40 | 2018 |
| Patient-derived melanoma organoid models facilitate the assessment of immunotherapies L Ou, S Liu, H Wang, Y Guo, L Guan, L Shen, R Luo, DE Elder, AC Huang, ... EBioMedicine 92, 2023 | 33 | 2023 |
| MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma L Guan, T Li, N Ai, W Wang, B He, Y Bai, Z Yu, M Li, S Dong, Q Zhu, ... Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019 | 26 | 2019 |
| De novo generation of SARS-CoV-2 antibody CDRH3 with a pre-trained generative large language model H He, B He, L Guan, Y Zhao, F Jiang, G Chen, Q Zhu, CYC Chen, T Li, ... Nature Communications 15 (1), 6867, 2024 | 17 | 2024 |
| Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method B He, P Lu, L Guan, T Li, L Zhang, QG Zhu, XX Ding, SM Zhang, XM Chen, ... Oncotarget 8 (61), 103919, 2017 | 10 | 2017 |
| Downregulation of TMEM220 Promotes Tumor Progression in Hepatocellular Carcinoma T Li, L Guan, G Tang, B He, L Huang, J Wang, M Li, Y Bai, X Li, H Zhang Cancer Gene Therapy, 2021 | 2 | 2021 |
| Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells Y Guo, H Wang, S Liu, X Zhang, X Zhu, L Huang, W Zhong, L Guan, ... Science Advances 11 (3), eadp9009, 2025 | | 2025 |
Ting LiUniversity of PennsylvaniaZweryfikowany adres z pennmedicine.upenn.edu